ELVN
Enliven Therapeutics Inc

1,244
Loading...
Loading...
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
62

Frequently Asked Questions

What is Market Cap of Enliven Therapeutics Inc?
What is the 52-week high for Enliven Therapeutics Inc?
What is the 52-week low for Enliven Therapeutics Inc?
What is Enliven Therapeutics Inc stock price today?
What was Enliven Therapeutics Inc stock price yesterday?
What is the PE ratio of Enliven Therapeutics Inc?
What is the Price-to-Book ratio of Enliven Therapeutics Inc?
What is the 50-day moving average of Enliven Therapeutics Inc?
How many employess does Enliven Therapeutics Inc has?

Latest ELVN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.